LTGO
Latigo Biotherapeutics, Inc.
16.60$
+4.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | -1.5% | -28.8% | +10.6% | |
| – | +13.7% | +17.9% | +8.3% | |
| – | – | -514.6% | – | |
| – | -67.6% | -100.0% | – | |
| – | -100.0% | +22,900.0% | – | |
| – | -127.6% | – | – | |
| – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.